Author: Becca Bucci
AMCP 2024
AAOS – American Academy of Orthopaedic Surgeons
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges
Therapeutic proteins (TP) – and more specifically monoclonal antibodies – are part of the therapeutic arsenal for the treatment of several diseases, providing effective and safe therapeutic solutions for patients. As part of the usual therapeutic practice, patients often receive drug combinations (TP/TP or TP/small molecules) and/or concomitant co-medications. Thus, drug-drug-interactions (DDIs) can be a … Continued
ACCAE (Asia Congress for Alternatives to Animal Experiments)
Biotech Showcase
BIO Partnering at JPM
Why you should select your drug formulation before starting clinical studies
Drug developers often rush through the discovery process to get into human testing. Most are so curious about their new target or molecule that they may forget that the pharmaceutical formulation process that can easily make or break their program. Once in human testing, revisiting these formulations is often time-consuming. By then, depending on drug … Continued
了解如何利用云计算的强大功能来简化工作流程！
Certara’s Phoenix Hosted package provides your PK scientists with a secured and validated Certara AWS workspace allowing for much quicker transit time from compliant data sources. It enhances productivity and supports compliance requirements by managing complex time-based data, the foundation for all PK/PD modeling. Certara’s deployment experts can optimize the Phoenix application configuration for increased … Continued
RAPS Sponsored Webcast: The EU Clinical Trials Regulation – Challenges Drug Developers Faced in the First 6 months
Join us on November 10th for this webcast being held in partnership with RAPS. The Clinical Trials Regulation (CTR) for the European Union (EU) took effect on 2022 年 1 月 31 日. Sites and sponsors must now embrace the new regulations to successfully run clinical trials across the European Union. Beginning on January 31st, 2023, sponsors are … Continued
